From Molecule Discovery to Commercialization: Why it’s Good to Have One CDMO for the Entire JourneyBy SEQENS North America
Novacap completes the acquisition of Seqens and expands its pharmaceutical offerings in the U.S.By SEQENS North America
Novacap to expand its pharmaceutical offering in the U.S. with the acquisition of SeqensBy SEQENS North America
